March 19, 2020 Media Statement: Labcorp announces ability to perform 20,000 tests per day, doubles its COVID-19 testing capacity in one week MARCH 19, 2020 - 5:0 Read more »
March 18, 2020 Information from LabCorp about coronavirus disease 2019 (COVID-19) MARCH 18, 2020 - 11: Read more »
March 16, 2020 Labcorp rapidly expanding its COVID-19 testing capacity, expects ability to perform 10,000 tests per day by the end of the week and 20,000 tests per day by the end of March MARCH 16, 2020 - 8:4 Read more »
December 12, 2019 Serum vedolizumab and corresponding anti-vedolizumab antibody: Analysis of over 6500 patient results using lab developed chemiluminescent immunoassays (ECLIA) Read more »
December 12, 2019 Serum ustekinumab and corresponding anti-ustekinumab antibody: Analysis of over 2000 patient results using lab developed chemiluminescent immunoassays (ECLIA) Read more »
